Evidence map›Paper›PMID 42275526›Full record

ArticleJMIR AI2026

A Structured Comparison of the Coalition for Health AI Responsible AI Guide and South Korea's Trustworthy AI Guideline for Health Care AI Assurance: Comparative Framework Analysis.

Trevor Vigeant, Aidan Tam, Qiming Shi, Jeroan Allison, MinJin Kim, Jin-Ah Sim, Dong Ok Won, DongSoo Shin, David M McManus, Jae Jun Lee and 2 more

Abstract read
In one paragraph

Article in JMIR AI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Trevor Vigeant *Department of Medicine, UMass Chan Medical School, Worcester, MA, United States.ORCID http://orcid.org/0009-0009-8753-9116
Aidan Tam *The Massachusetts AI Assurance for Healthcare (MAIAH) Lab, UMass Chan Medical School, Worceter, MA, United States.ORCID http://orcid.org/0009-0000-6204-7726
Qiming ShiDepartment of Medicine, UMass Chan Medical School, Worcester, MA, United States.ORCID http://orcid.org/0000-0001-5829-4345
Jeroan AllisonDepartment of Population and Quantitative Health Sciences, UMass Chan Medical School, Worcester, MA, United States.ORCID http://orcid.org/0000-0003-4472-2112
MinJin KimCollege of Nursing, University of Cincinnati, Cincinnati, OH, United States.ORCID http://orcid.org/0000-0002-9164-8149
Jin-Ah SimDepartment of Population and Quantitative Health Sciences, UMass Chan Medical School, Worcester, MA, United States.ORCID http://orcid.org/0000-0002-3494-3002
Dong Ok WonDepartment of Population and Quantitative Health Sciences, UMass Chan Medical School, Worcester, MA, United States.ORCID http://orcid.org/0000-0002-2839-6524
DongSoo ShinDepartment of Population and Quantitative Health Sciences, UMass Chan Medical School, Worcester, MA, United States.ORCID http://orcid.org/0000-0002-5289-3571
David M McManusDepartment of Medicine, UMass Chan Medical School, Worcester, MA, United States.ORCID http://orcid.org/0000-0002-9343-6203
Jae Jun LeeDepartment of Population and Quantitative Health Sciences, UMass Chan Medical School, Worcester, MA, United States.ORCID http://orcid.org/0000-0002-5418-500X
Jae Yong Yu *Department of Population and Quantitative Health Sciences, UMass Chan Medical School, Worcester, MA, United States.ORCID http://orcid.org/0000-0001-6922-8538
Adrian H Zai *The Massachusetts AI Assurance for Healthcare (MAIAH) Lab, UMass Chan Medical School, Worceter, MA, United States.ORCID http://orcid.org/0000-0002-2972-6839

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Trustworthy artificial intelligence (AI) in health care requires assurance frameworks that translate ethical principles into measurable governance and evaluation practices. While a growing number of AI assurance frameworks have been proposed, they differ substantially in governance structure, institutional embedding, and implementation mechanisms, reflecting differences in intended purpose and use. To date, few studies have applied standardized, rubric-based evaluation criteria to systematically compare how assurance instruments with different institutional origins operationalize ethical principles across the AI lifecycle. Objective: This study aimed to develop and apply a structured, rubric-based evaluation instrument to compare 2 health care AI assurance instruments, including the Coalition for Health AI (CHAI) responsible AI guide, a voluntary consortium-based instrument, and South Korea's Trustworthy AI guideline, a government-issued instrument. Methods: A 7-dimension evaluation rubric was developed based on a synthesis of established international AI assurance and governance instruments. The rubric covered core principles, AI lifecycle coverage, governance context, stakeholder breadth, operational maturity, instrument design and tools, and public accessibility. Seven independent evaluators with expertise in health care AI governance assessed each instrument using a 5-point ordinal rating scale (1=absent-5=comprehensive). Each evaluator independently scored the materials using a standardized rubric. Discrepancies were resolved through structured consensus discussions, with reference to rubric definitions and source documents. Final scores were determined based on documented evidence, requiring full consensus rather than averaging. Interrater reliability was assessed using Fleiss kappa. Results: Both instruments demonstrated strong alignment in core principles (CHAI: 4; Trustworthy AI Guideline: 5) and stakeholder breadth (both: 4). The government-issued Trustworthy AI Guideline exhibited broader AI lifecycle coverage (5 vs 4), a more formalized governance context (5 vs 3), and higher operational maturity (4 vs 2), reflecting stepwise oversight and formal embedded oversight mechanisms supported by legislation. In contrast, the voluntary CHAI instrument demonstrated greater emphasis on instrument design and implementation tools (4 vs 3) and higher public accessibility (5 vs 3), driven by open-access resources such as assurance standards guides and applied model cards. Interrater agreement of independent ratings was moderate to substantial (Fleiss kappa=0.47-0.64; P<.001), indicating consistent scoring patterns among evaluators. Conclusions: This comparative analysis indicates that voluntary and government-issued AI assurance instruments operationalize trustworthy AI principles in distinct but complementary ways. Voluntary instruments emphasize flexible tools and accessible implementation resources, while government-issued guidelines embed assurance functions within formal governance and oversight structures. Rather than representing competing models, these approaches address different assurance needs across the AI lifecycle. By identifying concrete areas of alignment and divergence, this study supports a more coherent comparison of assurance practices and highlights potential opportunities for alignment across documentation structures and evaluation approaches that can support safe, equitable, and scalable deployment of health care AI across diverse institutional contexts.

Indexed as

AIAI assuranceartificial intelligenceclinical decision supporthealth policyresponsible AI

Identifiers

PMID42275526
PMCPMC13256487

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.